IFNB1 and myeloid sarcoma: Among the most significantly DC genes, it is worthy mentioning the XIAP-associated factor 1 (XAF1) gene, which has been already associated with the response to IFN-β treatment in MS patients [58], also leading to the publication of a patent that stated its validity as a marker of IFN-β responsiveness [63].